Bali, Vishal
Weaver, Jessica
Turzhitsky, Vladimir
Schelfhout, Jonathan
Paudel, Misti L.
Hulbert, Erin
Peterson-Brandt, Jesse
Currie, Anne-Marie Guerra
Bakka, Dylan
Funding for this research was provided by:
Merck
Article History
Received: 24 October 2021
Accepted: 10 June 2022
First Online: 28 June 2022
Declarations
:
: All data were accessed in compliance with US patient confidentiality requirements, including the Health Insurance Portability and Accountability Act of 1996 regulations (HIPAA). All databases used are de-identified and fall under the US Department of Health and Human Services Policy for the Protection of Human Subjects, and therefore informed consent and Institutional Review Board approval were not required.
: Not applicable.
: VB, JW, VT, and JS are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and have stock ownership of Merck & Co., Inc., Rahway, NJ, USA. This study was sponsored by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. The following co-authors received funding for their work through by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA: MLP, EH, JPB, AMGC, and DB.